Ankit Jain
About Ankit Jain
Ankit Jain has 4 years in corporate governance. Holds Director and Designated Partner roles. Currently with 7 companies, including Noosyn Tech Private Limited and Nabu Health Private Limited. Engaged in Technology, Healthcare and more. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Noosyn Tech Private Limited
U72900HR2016PTC058285
|
Director | 30 Jul 2022 | 2016 | Active |
Nabu Health Private Limited
U85100DL2021PTC390427
|
Director | 25 Nov 2021 | 2021 | Active |
Zonne Ventures Private Limited
U85110DL2022PTC394693
|
Director | 07 Mar 2022 | 2022 | Active |
|
Swastika Mediways Private Limited
U85300DL2021PTC385999
|
Director | 02 Sep 2021 | 2021 | Active |
|
Growterrain Advisors Llp
ABZ-4829
|
Designated Partner | 16 Dec 2022 | 2022 | Active |
|
Eazyb Supplychain Private Limited
U46497DL2025PTC445599
|
Director | 03 Apr 2025 | 2025 | Active |
|
Routine Regime Private Limited
U62099DL2023PTC424564
|
Director | 29 Dec 2023 | 2023 | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ankit Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankit Jain
Ankit Jain has 4 years in corporate governance. Holds Director and Designated Partner roles. Currently with 7 companies, including Noosyn Tech Private Limited and Nabu Health Private Limited. Engaged in Technology, Healthcare and more. Contributes to corporate operations.
Ankit Jain is associated with 7 companies as Director and Designated Partner.
Ankit Jain has expertise in Technology, Healthcare and other sectors.
Ankit Jain has 4 years in corporate governance.